Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020)
Neurocrine Biosciences (NBIX) reported Change in Working Capital of $4.1 million for Q1 2020, up 224.24% on a YoY basis from $1.3 million in Q2 2019, and up 224.24% quarter-over-quarter from -$3.3 million in Q1 2019.
Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020) Analysis & Trends
Neurocrine Biosciences has reported Change in Working Capital for 2 years, with the latest figure at $4.1 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 215.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2019 | -3.30 Mn |
| Mar 31, 2019 | -3.30 Mn |